Trinity Biotech - 25 Year Stock Price History | TRIB

Historical daily share price chart and data for Trinity Biotech since 1995 adjusted for splits. The latest closing stock price for Trinity Biotech as of September 25, 2020 is 2.00.
  • The all-time high Trinity Biotech stock closing price was 29.76 on March 08, 2000.
  • The Trinity Biotech 52-week high stock price is 3.28, which is 64% above the current share price.
  • The Trinity Biotech 52-week low stock price is 0.56, which is 72% below the current share price.
  • The average Trinity Biotech stock price for the last 52 weeks is 1.45.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Trinity Biotech Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 1.6286 1.0700 3.1700 0.6200 2.0000 93.54%
2019 1.9428 2.3100 3.2200 0.6931 1.0334 -54.87%
2018 4.4185 5.1800 6.0600 2.1400 2.2900 -55.10%
2017 5.6609 6.9600 7.0400 4.5000 5.1000 -26.30%
2016 10.3162 11.6800 13.5300 6.3100 6.9200 -41.16%
2015 15.8877 18.1500 20.0500 10.8300 11.7600 -32.84%
2014 22.1502 24.9100 27.8700 16.0500 17.5100 -30.35%
2013 19.1517 14.6800 25.6300 14.5800 25.1400 74.34%
2012 12.1019 10.1000 15.4000 9.8400 14.4200 41.65%
2011 9.6976 8.5600 10.8500 8.3000 10.1800 15.55%
2010 6.1466 3.9775 8.9000 3.8400 8.8100 118.07%
2009 3.2072 1.6400 4.9500 1.0500 4.0400 152.50%
2008 3.7129 6.5900 6.9500 1.2500 1.6000 -76.51%
2007 9.8960 8.7900 11.7500 5.7200 6.8101 -20.54%
2006 8.5701 8.2100 9.5400 7.0900 8.5700 5.02%
2005 8.2098 11.7200 11.7200 6.2800 8.1600 -31.08%
2004 13.0115 21.2400 21.2400 10.1200 11.8400 -46.95%
2003 11.0994 5.8000 24.7560 5.0000 22.3200 313.33%
2002 5.3843 6.0000 7.3600 3.7200 5.4000 -11.18%
2001 7.6525 9.0000 12.0000 4.5600 6.0800 -32.44%
2000 13.4112 7.0000 29.7600 7.0000 9.0000 33.14%
1999 6.8370 5.8800 9.0000 4.6400 6.7600 29.01%
1998 7.2665 8.2400 10.2400 3.7600 5.2400 -33.50%
1997 10.1412 9.2400 12.6400 6.5200 7.8800 -15.81%
1996 14.8389 14.4800 25.5200 9.0000 9.3600 -39.69%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.048B $0.090B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.682B 33.53
Medtronic (MDT) Ireland $136.129B 25.64
Stryker (SYK) United States $74.576B 28.92
Boston Scientific (BSX) United States $53.107B 30.68
Lonza Group Ag (LZAGY) Switzerland $45.620B 0.00
Baxter (BAX) United States $39.840B 24.37
Terumo (TRUMY) Japan $30.003B 38.35
Zimmer Biomet Holdings (ZBH) United States $27.355B 22.70
EssilorLuxottica Societe Anonyme (ESLOY) France $27.164B 0.00
ResMed (RMD) United States $24.364B 35.32
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.383B 0.00
Bio-Rad Laboratories (BIO) United States $14.666B 66.33
Insulet (PODD) United States $14.217B 601.53
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.053B 42.66
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.140B 10.54
Hill-Rom Holdings (HRC) United States $5.406B 13.42
Canopy Growth (CGC) Canada $5.305B 0.00
Haemonetics (HAE) United States $4.393B 29.27
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.250B 0.00
Neogen (NEOG) United States $3.902B 63.97
ICU Medical (ICUI) United States $3.841B 29.31
Envista Holdings (NVST) United States $3.701B 25.24
Abcam (ABCZY) $3.220B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.058B 0.00
TG Therapeutics (TGTX) United States $3.007B 0.00
National Vision Holdings (EYE) United States $2.947B 458.00
NuVasive (NUVA) United States $2.507B 34.94
Agios Pharmaceuticals (AGIO) United States $2.341B 0.00
AtriCure (ATRC) United States $1.724B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.632B 148.92
NanoString Technologies (NSTG) United States $1.620B 0.00
Cardiovascular Systems (CSII) United States $1.415B 0.00
MacroGenics (MGNX) United States $1.336B 0.00
Owens & Minor (OMI) United States $1.295B 29.01
Aphria (APHA) Canada $1.218B 0.00
InMode (INMD) Israel $1.125B 28.37
Cerus (CERS) United States $0.980B 0.00
Quanterix (QTRX) United States $0.898B 0.00
PetIQ (PETQ) United States $0.882B 25.30
BioLife Solutions (BLFS) United States $0.835B 435.00
Lantheus Holdings (LNTH) United States $0.804B 11.14
OraSure Technologies (OSUR) United States $0.762B 0.00
Phibro Animal Health (PAHC) United States $0.713B 16.32
LeMaitre Vascular (LMAT) United States $0.685B 41.80
Meridian Bioscience (VIVO) United States $0.665B 15.36
Vapotherm (VAPO) United States $0.650B 0.00
Aurora Cannabis (ACB) Canada $0.600B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.560B 79.08
Zynex (ZYXI) United States $0.553B 48.27
Omeros (OMER) United States $0.536B 0.00
Surmodics (SRDX) United States $0.517B 56.72
VAREX IMAGING (VREX) United States $0.460B 19.93
Cytosorbents (CTSO) United States $0.327B 0.00
Viemed Healthcare (VMD) United States $0.325B 11.61
HEXO (HEXO) $0.312B 0.00
Utah Medical Products (UTMD) United States $0.285B 24.44
InfuSystems Holdings (INFU) United States $0.265B 50.42
Neptune Wellness Solutions (NEPT) Canada $0.242B 0.00
Surface Oncology (SURF) United States $0.240B 0.00
Organigram Holdings (OGI) Canada $0.210B 0.00
Female Health (VERU) United States $0.184B 0.00
Chimerix (CMRX) United States $0.164B 0.00
Bovie Medical (APYX) United States $0.154B 0.00
Wound Management Technologies (SMTI) United States $0.152B 0.00
Fonar (FONR) United States $0.142B 12.58
Exagen (XGN) United States $0.137B 0.00
Liberty Health Sciences (LHSIF) United States $0.128B 0.00
Evolus (EOLS) United States $0.122B 0.00
Capricor Therapeutics (CAPR) United States $0.098B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.085B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Rockwell Medical (RMTI) United States $0.077B 0.00
United-Guardian (UG) United States $0.069B 15.39
Oramed Pharmaceuticals (ORMP) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.061B 0.00
MTech Acquisition (KERN) United States $0.051B 0.00
Nephros (NEPH) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
FSD PHARMA INC (HUGE) Canada $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
NF Energy Saving (BIMI) China $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00